Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2017

Open Access 01-10-2017 | Case Report

Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration

Authors: Tsutomu Takeda, Daisuke Asaoka, Yuzuru Tajima, Kenshi Matsumoto, Naoto Takeda, Takahumi Hiromoto, Shoki Okubo, Hiroaki Saito, Tomonori Aoyama, Tomoyoshi Shibuya, Naoto Sakamoto, Mariko Hojo, Taro Osada, Akihito Nagahara, Takashi Yao, Sumio Watanabe

Published in: Clinical Journal of Gastroenterology | Issue 5/2017

Login to get access

Abstract

We report a rare case of hemorrhagic gastric polyps resulting in anemia during long-term proton pump inhibitor (PPI) administration that endoscopically looked like a fundic gland polyp (FGP). A 44-year-old man presented complaining of anemia and tarry stools. Esophagogastroduodenoscopy (EGD) demonstrated multiple white edematous polyps in the corpus and antrum, which were considered to be FGPs. We attempted endoscopic hemostasis but hemorrhaging increased because of hemorrhagic polyps and vulnerable gastric mucosa. Re-bleeding occurred several times. Polyp resection was performed at 24 polyp sites. We also ceased the administration of PPI. Microscopically, polyps showed characteristics of hyperplasia in the foveolar epithelium, extensions of fundic glands, and edema of the stroma. The proliferation of parietal and chief cells was also observed. Immunohistochemically, aquaporin-4 (AQP4) and KCNQ1-positive parietal cells and dilated mucous glands were found from the basal side to the apical side of the mucosa. These findings were compatible with the development of lesions associated with the long-term administration of PPI. EGD revealed an improvement in the vulnerability of gastric mucosa and the development of polyps, with no further gastric polyps observed 1 year after discharge. Bleeding from polyps resembling FGPs is generally rare, with indications that long-term PPI administration may induce such bleeding.
Literature
1.
go back to reference Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust. 1992;157:287–8.PubMed Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust. 1992;157:287–8.PubMed
2.
go back to reference Jalving M, Koornstra JJ, Wesseling J, et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24:1341–8.CrossRefPubMed Jalving M, Koornstra JJ, Wesseling J, et al. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24:1341–8.CrossRefPubMed
3.
go back to reference Hongo M, Fujimoto K, Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol. 2010;45:618–24.CrossRefPubMed Hongo M, Fujimoto K, Gastric Polyps Study Group. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. J Gastroenterol. 2010;45:618–24.CrossRefPubMed
4.
go back to reference Vieth M, Stolte M, et al. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116:716–20.CrossRefPubMed Vieth M, Stolte M, et al. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116:716–20.CrossRefPubMed
5.
go back to reference Shand AG, Taylor AC, Banerjee M, et al. Gastric fundic gland polyps in south-east Scotland: absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. J Gastroenterol Hepatol. 2002;17:1161–4.CrossRefPubMed Shand AG, Taylor AC, Banerjee M, et al. Gastric fundic gland polyps in south-east Scotland: absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. J Gastroenterol Hepatol. 2002;17:1161–4.CrossRefPubMed
6.
go back to reference Tsuchigame T, Saito R, Ogata Y, et al. Clinical evaluation of gastric fundic gland polyps without familial polyposis coli. Abdom Imaging. 1995;20:101–5.CrossRefPubMed Tsuchigame T, Saito R, Ogata Y, et al. Clinical evaluation of gastric fundic gland polyps without familial polyposis coli. Abdom Imaging. 1995;20:101–5.CrossRefPubMed
8.
go back to reference Hollingworth S, Duncan EL, Martin JH. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf. 2010;19:1019–24.CrossRefPubMed Hollingworth S, Duncan EL, Martin JH. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf. 2010;19:1019–24.CrossRefPubMed
9.
go back to reference Cats A, Schenk BE, Bloemena E, et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000;31:684–90.CrossRefPubMed Cats A, Schenk BE, Bloemena E, et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000;31:684–90.CrossRefPubMed
10.
go back to reference Matsuzaki J, Suzuki H, Minegishi Y, et al. Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse. Dig Dis Sci. 2010;55:3339–48.CrossRefPubMed Matsuzaki J, Suzuki H, Minegishi Y, et al. Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse. Dig Dis Sci. 2010;55:3339–48.CrossRefPubMed
11.
go back to reference Fukuhara S, Matsuzaki J, Tsugawa H, et al. Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice and Helicobacter pylori-infected mice. J Gastroenterol Hepatol. 2014;29:53–9.CrossRefPubMed Fukuhara S, Matsuzaki J, Tsugawa H, et al. Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice and Helicobacter pylori-infected mice. J Gastroenterol Hepatol. 2014;29:53–9.CrossRefPubMed
13.
go back to reference Anglin R, Yuan Y, Moayyedi P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:811–9.CrossRefPubMed Anglin R, Yuan Y, Moayyedi P, et al. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:811–9.CrossRefPubMed
14.
go back to reference Itatsu T, Nagahara A, Hojo M, et al. Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease. Intern Med. 2011;50:713–7.CrossRefPubMed Itatsu T, Nagahara A, Hojo M, et al. Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease. Intern Med. 2011;50:713–7.CrossRefPubMed
Metadata
Title
Hemorrhagic polyps formed like fundic gland polyps during long-term proton pump inhibitor administration
Authors
Tsutomu Takeda
Daisuke Asaoka
Yuzuru Tajima
Kenshi Matsumoto
Naoto Takeda
Takahumi Hiromoto
Shoki Okubo
Hiroaki Saito
Tomonori Aoyama
Tomoyoshi Shibuya
Naoto Sakamoto
Mariko Hojo
Taro Osada
Akihito Nagahara
Takashi Yao
Sumio Watanabe
Publication date
01-10-2017
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 5/2017
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-017-0756-x

Other articles of this Issue 5/2017

Clinical Journal of Gastroenterology 5/2017 Go to the issue